Skip to main
FATE
FATE logo

Fate Therapeutics (FATE)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Fate Therapeutics (FATE) Stock

About Fate Therapeutics (FATE)

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendle...read more
Market cap$128.39M
Today's volume1.22M
Revenue (TTM)$13.34M
Avg. daily volume2.12M
EBITDA (TTM)-$168.28M
Open$1.12
Price / earnings ratio-0.75x
Today's range$1.11 - $1.16
Debt / equity28.89x
52 week range$0.66 - $5.92
5 year debt / equity22.56x
Beta (LTM)1.28x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio8.81x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

Fate Therapeutics Stock Rating

What analysts recommend for FATE stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 4%
Strong Sell 4%

Frequently Asked Questions (FAQ)

As of Jul 02, 2025, the market cap for FATE stock is $128.39M

The current P/E ratio for FATE stock is -0.75

The 52-week high for FATE stock is $5.92. The current FATE stock price $undefined is 100.00% below its 52-week high

The 52-week low for FATE stock is $0.66. The current FATE stock price $undefined has increased 100.00% from its 52-week low

No, the FATE stock does not pay dividends to its shareholders

The target price for FATE stock is $10.65 based on the average of what a group of analyst think FATE stock could be worth at a future date. This is not a prediction by Public.com

How to buy FATE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in FATE stock

    Navigate to the Explore page. Then, type FATE into the search bar. When you see FATE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased FATE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Fate Therapeutics Stock Earnings

The value each FATE share was expected to gain vs. the value that each FATE share actually gained.

Fate Therapeutics (FATE) reported Q1 2025 earnings per share (EPS) of -$0.32, beating estimates of -$0.46 by 30.43%. In the same quarter last year, Fate Therapeutics's earnings per share (EPS) was -$0.47. Fate Therapeutics is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.33.

Buy Fate Therapeutics (FATE) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.